{"id":"https://openalex.org/W7204125747","doi":"https://doi.org/10.1201/9781003772019-8","title":"Indole-Based Compounds for the Treatment of Neurological Disorders","display_name":"Indole-Based Compounds for the Treatment of Neurological Disorders","publication_year":2026,"publication_date":"2026-08-24","ids":{"openalex":"https://openalex.org/W7204125747","doi":"https://doi.org/10.1201/9781003772019-8"},"language":"en","primary_location":{"id":"doi:10.1201/9781003772019-8","doi":"https://doi.org/10.1201/9781003772019-8","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003772019-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nitrogen Heterocycles in Neurodegenerative Disorders","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W7204085688","display_name":"Nitrogen Heterocycles in Neurodegenerative Disorders"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022360340","display_name":"Mohammed Er-rajy","orcid":"https://orcid.org/0000-0001-5460-684X","observed_orcids":["https://orcid.org/0000-0001-5460-684X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Er-Rajy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5460-684X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074546459","display_name":"Mohamed El fadili","orcid":"https://orcid.org/0000-0002-2211-3298","observed_orcids":["https://orcid.org/0000-0002-2211-3298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed El Fadili","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2211-3298","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115659813","display_name":"Mohammed Zerrouk","orcid":"https://orcid.org/0009-0001-8219-8078","observed_orcids":["https://orcid.org/0009-0001-8219-8078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Zerrouk","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-8219-8078","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147960677","display_name":"Arzine Aziz","orcid":"https://orcid.org/0009-0007-2632-2314","observed_orcids":["https://orcid.org/0009-0007-2632-2314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arzine Aziz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-2632-2314","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022879238","display_name":"Khalil Azzaoui","orcid":"https://orcid.org/0000-0003-0202-0112","observed_orcids":["https://orcid.org/0000-0003-0202-0112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khalil Azzaoui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0202-0112","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031613832","display_name":"Menana Elhallaoui","orcid":"https://orcid.org/0000-0002-9863-6298","observed_orcids":["https://orcid.org/0000-0002-9863-6298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Menana El Hallaoui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9863-6298","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"115","last_page":"128"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3871999979019165,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3871999979019165,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.24230000376701355,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.125900000333786,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9369999766349792},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9729999899864197},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9559999704360962},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":1.0},{"id":"https://openalex.org/keywords/nitrogen-containing-heterocycles","display_name":"nitrogen heterocycles","score":0.9150000214576721},{"id":"https://openalex.org/keywords/privileged-scaffolds","display_name":"privileged scaffolds","score":0.7360000014305115},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.828000009059906},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.6079999804496765},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.796999990940094},{"id":"https://openalex.org/keywords/computer-aided-drug-design","display_name":"computer-aided drug design","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.670799970626831},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.600600004196167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5442000031471252},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38370001316070557},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.37790000438690186},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.37049999833106995},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.32679998874664307},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.3174999952316284},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.31439998745918274},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30309998989105225},{"id":"https://openalex.org/C2984915365","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive impairment","level":3,"score":0.29910001158714294},{"id":"https://openalex.org/C2988438704","wikidata":"https://www.wikidata.org/wiki/Q2996165","display_name":"Motor function","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C3020442560","wikidata":"https://www.wikidata.org/wiki/Q4971815","display_name":"Broad spectrum","level":2,"score":0.2766999900341034},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.2653999924659729},{"id":"https://openalex.org/C2987857752","wikidata":"https://www.wikidata.org/wiki/Q12147","display_name":"Human health","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C2779632907","wikidata":"https://www.wikidata.org/wiki/Q13444883","display_name":"Brain Structure and Function","level":3,"score":0.2619999945163727},{"id":"https://openalex.org/C3018390542","wikidata":"https://www.wikidata.org/wiki/Q1073","display_name":"Brain function","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2535000145435333},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.2508000135421753}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003772019-8","doi":"https://doi.org/10.1201/9781003772019-8","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003772019-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nitrogen Heterocycles in Neurodegenerative Disorders","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396611146","https://openalex.org/W4411009207","https://openalex.org/W7167045702","https://openalex.org/W7119538805","https://openalex.org/W7204110271","https://openalex.org/W6912056794","https://openalex.org/W7164152017","https://openalex.org/W7204092986","https://openalex.org/W4413170111","https://openalex.org/W4310803234"],"abstract_inverted_index":{"Neurodegeneration":[0],"represents":[1],"a":[2,56,62,107,132,155],"progressive":[3],"and":[4,16,22,37,52,78,83,90,121,141,166,190,199,204],"irreversible":[5],"process":[6],"that":[7,66],"leads":[8],"to":[9,68,117,123,150,187],"the":[10,20,42,71,86,104,162,173,180,201],"gradual":[11],"loss":[12],"of":[13,44,76,88,135,145,158,169,175],"neuronal":[14],"structure":[15],"function":[17],"in":[18,81,110,161,206],"both":[19],"central":[21],"peripheral":[23],"nervous":[24],"systems.":[25],"This":[26,152],"deterioration":[27],"manifests":[28],"clinically":[29],"through":[30],"cognitive":[31],"impairment,":[32],"memory":[33],"decline,":[34],"behavioral":[35],"changes,":[36],"motor":[38],"dysfunction,":[39],"ultimately":[40],"compromising":[41],"quality":[43],"life.":[45],"Neurodegenerative":[46],"disorders":[47],"such":[48],"as":[49,210],"Alzheimer's,":[50],"Parkinson's,":[51],"Huntington's":[53],"diseases":[54],"constitute":[55],"major":[57],"global":[58],"health":[59],"challenge,":[60],"generating":[61],"considerable":[63],"socio-economic":[64],"burden":[65],"continues":[67],"rise":[69],"with":[70,125],"aging":[72],"population.":[73],"Despite":[74],"decades":[75],"research":[77,185],"numerous":[79],"advances":[80,160],"neurobiology":[82],"medicinal":[84,111],"chemistry,":[85],"discovery":[87],"effective":[89],"safe":[91],"therapeutic":[92],"agents":[93,212],"remains":[94],"elusive.":[95],"In":[96],"this":[97],"context,":[98],"nitrogen-containing":[99],"heterocyclic":[100],"compounds\u2014particularly":[101],"those":[102],"featuring":[103],"indole":[105],"nucleus,":[106],"privileged":[108],"scaffold":[109],"chemistry\u2014have":[112],"gained":[113],"significant":[114],"attention":[115],"owing":[116],"their":[118],"structural":[119],"versatility":[120],"ability":[122],"interact":[124],"multiple":[126],"biological":[127],"targets.":[128],"Indole-based":[129],"derivatives":[130],"exhibit":[131],"wide":[133],"spectrum":[134],"pharmacological":[136],"effects,":[137],"including":[138],"antioxidant,":[139],"anti-inflammatory,":[140],"enzyme-inhibitory":[142],"activities,":[143],"all":[144],"which":[146],"are":[147],"highly":[148],"relevant":[149],"neuroprotection.":[151],"chapter":[153],"provides":[154],"comprehensive":[156],"overview":[157],"recent":[159],"rational":[163],"design,":[164],"synthesis,":[165],"computational":[167],"studies":[168],"indole-based":[170],"compounds":[171],"for":[172,213],"treatment":[174],"neurodegenerative":[176,214],"diseases.":[177],"It":[178],"discusses":[179],"strategies":[181],"adopted":[182],"by":[183],"various":[184],"groups":[186],"optimize":[188],"pharmacodynamic":[189],"pharmacokinetic":[191],"properties,":[192],"highlights":[193],"key":[194],"molecular":[195],"mechanisms":[196],"underlying":[197],"neuroprotection,":[198],"outlines":[200],"emerging":[202],"challenges":[203],"perspectives":[205],"developing":[207],"indole-derived":[208],"therapeutics":[209],"potential":[211],"disorders.":[215]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-08-25T00:00:00"}
